Last month's top 10 short squeeze candidates — how did they actually do?
On 2026-05-12, our composite squeeze score flagged the ten names below as the highest-readiness candidates on the board — high short interest, rising days-to-cover, and at least one bullish technical setup confirming the squeeze thesis.
Over the next 30 calendar days (through 2026-06-10), the basket punished anyone who simply bought and held. The average peak gain was +11.9%, against an average drawdown of -14.7% and an average buy-and-hold return of -6.4%. 3 of 10 names closed green; 1 lost more than 20%.
The screener surfaced modest but realistic swings — IMVT alone touched +26.6% intra-window — but as is typical for short squeeze setups, the winners failed to outrun the losers when held to today. Most names rolled over before any squeeze fully developed. Below is each candidate, in order of composite score, with the price action that followed.
The numbers, top-to-bottom
| # | Ticker | Company | Score | SI % | DTC | Peak | Drawdown | Held to today |
|---|---|---|---|---|---|---|---|---|
| 1 | HPK | HighPeak Energy, Inc. Common Stock | 98.1 | 30.4% | 10.3 | +22.5% | -3.8% | +18.7% |
| 2 | PRME | Prime Medicine, Inc. Common Stock | 94.1 | 43.4% | 18.6 | +9.4% | -18.8% | -17.9% |
| 3 | IBRX | ImmunityBio, Inc. Common Stock | 92.4 | 37.5% | 10.6 | +6.4% | -16.3% | -14.0% |
| 4 | OFRM | Once Upon a Farm, PBC | 92.1 | 26.0% | 9.1 | +8.5% | -10.4% | +7.8% |
| 5 | IMVT | Immunovant, Inc. Common Stock | 91.6 | 23.5% | 10.5 | +26.6% | -10.1% | +8.8% |
| 6 | GLSI | Greenwich LifeSciences, Inc. | 91.3 | 26.4% | 11.0 | +21.1% | -15.4% | -10.5% |
| 7 | CRVS | Corvus Pharmaceuticals, Inc. | 91.0 | 31.7% | 11.5 | +1.1% | -32.2% | -30.1% |
| 8 | EVMN | Evommune, Inc. | 90.4 | 32.3% | 13.3 | +6.5% | -15.1% | -9.7% |
| 9 | WBTN | WEBTOON Entertainment Inc. Common Stock | 90.0 | 33.5% | 21.4 | +14.0% | -9.7% | -7.9% |
| 10 | CRK | Comstock Resources, Inc. | 90.0 | 26.7% | 10.3 | +3.4% | -15.5% | -9.2% |
Ticker by ticker
#1. HPK — HighPeak Energy, Inc. Common Stock · $897M · score 98.1
HPK (HighPeak Energy, Inc. Common Stock) ($897M) Oil & Gas sector — entered the window at $6.89. A critical-risk reading on the squeeze board: a composite of 98.1 backed by 30.4% of float and 10.3 days-to-cover. The squeeze did show up — price ran to $8.44 by the 6th session, a +22.5% move from entry. Pullbacks were shallow; the low at $6.63 on the 2nd session was just -3.8% from the entry. Held to today, the trade prints +18.7% — a clear win for the composite score.
#2. PRME — Prime Medicine, Inc. Common Stock · $641M · score 94.1
PRME (Prime Medicine, Inc. Common Stock) ($641M) Healthcare - Genomics & Precision Medicine sector — entered the window at $3.30. A critical-risk reading on the squeeze board: a composite of 94.1 backed by 43.4% of float and 18.6 days-to-cover. The squeeze never really fired — the best print was $3.61 on the 16th session, only +9.4% off the entry. The other side of the trade hurt: $2.68 on the 5th session (-18.8% from entry) was the worst of it. As of yesterday's close the trade sits at -17.9% — the setup looked good on paper but the market disagreed.
#3. IBRX — ImmunityBio, Inc. Common Stock · $7.9B · score 92.4
IBRX (ImmunityBio, Inc. Common Stock) ($7.9B) Healthcare - Oncology sector — entered the window at $8.12. The score flagged it as critical-risk squeeze: a composite of 92.4 backed by 37.5% of float and 10.6 days-to-cover. Bulls couldn't get traction; the 6th session marked the high at $8.64 (+6.4% from entry) and that was it. Short sellers had their innings too — the 17th session bottomed at $6.79, -16.3% below the entry close. Held to today, the trade is down -14.0% — the early pop didn't hold and longs got hurt.
#4. OFRM — Once Upon a Farm, PBC · $647M · score 92.1
OFRM (Once Upon a Farm, PBC) ($647M) Consumer Brands & Retail sector — entered the window at $16.09. On the day, our composite tagged it critical: a composite of 92.1 backed by 26.0% of float and 9.1 days-to-cover. Squeeze risk on paper, no squeeze in the tape — high of $17.45 on the 20th session, just +8.5% above entry. Drawdown stayed manageable — only -10.4% to $14.41 on the 14th session. As of last night's close the position is +7.8% from entry, a wash after a volatile month.
#5. IMVT — Immunovant, Inc. Common Stock · $6.8B · score 91.6
IMVT (Immunovant, Inc. Common Stock) ($6.8B) Biotech - Drug Development sector — entered the window at $28.65. A critical-risk reading on the squeeze board: a composite of 91.6 backed by 23.5% of float and 10.5 days-to-cover. The squeeze did show up — price ran to $36.28 by the 6th session, a +26.6% move from entry. Pullbacks were shallow; the low at $25.75 on the 5th session was just -10.1% from the entry. Held to today, the trade is essentially scratch at +8.8%.
#6. GLSI — Greenwich LifeSciences, Inc. · $363M · score 91.3
GLSI (Greenwich LifeSciences, Inc.) ($363M) Healthcare - Oncology sector — entered the window at $24.71. The score flagged it as critical-risk squeeze: a composite of 91.3 backed by 26.4% of float and 11.0 days-to-cover. The setup worked: the 13th session brought a high of $29.93, a +21.1% swing from the entry close. Short sellers had their innings too — the 18th session bottomed at $20.91, -15.4% below the entry close. Held to today, the trade is down -10.5% — the early pop didn't hold and longs got hurt.
#7. CRVS — Corvus Pharmaceuticals, Inc. · $1.0B · score 91.0
CRVS (Corvus Pharmaceuticals, Inc.) ($1.0B) Healthcare - Oncology sector — entered the window at $15.97. On the day, our composite tagged it critical: a composite of 91.0 backed by 31.7% of float and 11.5 days-to-cover. Squeeze risk on paper, no squeeze in the tape — high of $16.14 on the 1st session, just +1.1% above entry. Drawdown was steep — the 19th session saw price tag $10.83, a -32.2% retrace from the start. Held to today, the trade prints a brutal -30.1%. The squeeze never showed up; the sellers did.
#8. EVMN — Evommune, Inc. · $837M · score 90.4
EVMN (Evommune, Inc.) ($837M) Biotech - Drug Development sector — entered the window at $22.69. The score flagged it as critical-risk squeeze: a composite of 90.4 backed by 32.3% of float and 13.3 days-to-cover. Bulls couldn't get traction; the 10th session marked the high at $24.16 (+6.5% from entry) and that was it. Short sellers had their innings too — the 18th session bottomed at $19.27, -15.1% below the entry close. Held to today, the trade is down -9.7% — the early pop didn't hold and longs got hurt.
#9. WBTN — WEBTOON Entertainment Inc. Common Stock · $1.7B · score 90.0
WBTN (WEBTOON Entertainment Inc. Common Stock) ($1.7B) Entertainment & Gaming sector — entered the window at $12.16. On the day, our composite tagged it critical: a composite of 90.0 backed by 33.5% of float and 21.4 days-to-cover. The thesis paid off briefly — buyers pushed the tape to $13.87 on the 1st session for a +14.0% pop. Drawdown stayed manageable — only -9.7% to $10.98 on the 20th session. Net of the round trip, the position prints -7.9%, a clear loss for the buy-and-hold variant.
#10. CRK — Comstock Resources, Inc. · $3.9B · score 90.0
CRK (Comstock Resources, Inc.) ($3.9B) Oil & Gas sector — entered the window at $14.72. A critical-risk reading on the squeeze board: a composite of 90.0 backed by 26.7% of float and 10.3 days-to-cover. The squeeze never really fired — the best print was $15.22 on the 3rd session, only +3.4% off the entry. The other side of the trade hurt: $12.44 on the 19th session (-15.5% from entry) was the worst of it. As of yesterday's close the trade sits at -9.2% — the setup looked good on paper but the market disagreed.